Silence Therapeutics plc

NASDAQ:SLN

Biotechnology

Healthcare
$19.82 +2.81%

+$0.19 today

Market cap
$936.18M
Beta
1.48
P/E (TTM)
-3.9
EPS (TTM)
-$1.80
52W Low $4.19High $8.40

Volume 1.47M

Average 0.31M

Balance Sheet

Inspect the capital base behind the business.

Assets

$131.44M

FY 2025 · Annual

-18.8% YoY

Liabilities

$69.14M

FY 2025 · Annual

+26.1% YoY

Equity

$62.30M

FY 2025 · Annual

-41.8% YoY

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · GBP
FY2022
Dec 2022 · GBP
FY2023
Dec 2023 · GBP
FY2024
Dec 2024 · GBP
FY2025
Dec 2025 · USD
Cash & Equivalents73.54M54.82M68.79M96.95M11.28M
Short-term Investments016.33M020.78M73.84M
Net Receivables331K915K23.98M21.5M24.61M
Inventory00000
Other Current Assets8.16M16.43M18.58M20.72M0
Total Current Assets86.33M96.69M103.15M149.72M118.66M
Property, Plant & Equipment (Net)1.94M2.2M2.31M1.58M1.75M
Goodwill7.59M8.01M9.98M7.51M10.62M
Intangible Assets24K320K362K249.32K288K
Long-term Investments301K284K000
Tax Assets00000
Other Non-current Assets003.65M2.87M127K
Total Non-current Assets9.86M10.81M16.3M12.2M12.78M
Total Assets96.19M107.5M119.45M161.92M131.44M
Account Payables4.07M3.19M3.35M2.95M4.41M
Short-term Debt00228K00
Tax Payables00475.5K715.98K0
Deferred Revenue006.57M244.52K168K
Other Current Liabilities4.43M9.45M8.58M2.75M5.94M
Total Current Liabilities15.17M21.94M22.34M13.44M13.61M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0075M41.38M55.45M
Other Non-current Liabilities72.5M63.49M000
Total Non-current Liabilities72.5M63.49M75.12M41.38M55.53M
Total Liabilities87.67M85.43M97.46M54.83M69.14M
Common Stock4.49M5.39M8.85M8.22M10.29M
Retained Earnings(222.97M)(263.26M)(431.89M)(378.8M)(562.57M)
Accumulated OCI42.67M53.27M40.36M(9.41M)(2.98M)
Other Stockholders Equity00(51.09M)00
Minority Interest00000
Total Equity8.53M22.07M21.99M107.1M62.3M
Total Debt137K446K346K93.49K160K
Net Debt(73.4M)(54.37M)(68.44M)(96.86M)(11.12M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$5.7M
Short-term Investments$64.4M
Receivables$22.2M
Other Current$10.6M
Total Current Assets$102.9M
PP&E (Net)$1.5M
Goodwill$10.4M
Intangible Assets$248.0K
Other Non-current$127.0K
Total Non-current Assets$12.3M
Total Assets$115.1M

Analysis

Selected assets total $115.1M for Latest. The largest visible component is Short-term Investments at $64.4M, about 56.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
DEFA14ADEFA14A filingNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 12, 2026
SC 13GSC 13G filingNov 5, 2026

How much cash does SLN have?

Silence Therapeutics plc (SLN) reported $11.28M in cash and equivalents in fiscal 2025.

How much debt does SLN carry?

Silence Therapeutics plc (SLN) reported $160,000.00 of total debt, with net debt of -$11.12M.